We are proud to announce our partnership with @GeistlichPharmaAG to distribute the NUsurface® medial meniscus replacement prosthesis in Switzerland #NUsurface #artificialmeniscus #MEFISTO_H2020 #GeistlichPharmaAG
businesswire.com/news/home/2…
businesswire.com/news/home/2…
Active Implants was featured in BTIG’s recent Medical Technology and Digital Health Industry Report. Download the report here: bit.ly/3dXkm9f
1
5
We are pleased to partner with Joint Operations to bring the NUsurface Implant to the UK market. #NUsurface #artificialmeniscus #meniscustear @JO_SaveTheJoint
Thank you to @Profverdonk for educating the UK user group @ the NUSurface training meeting. Thank you to all the delegates for joining us.
#savethemeniscus but if you can’t, #savethejoint by protecting the chondral surface #NUSurface
Looking for information on the development of our NUsurface Meniscus Implant? Check out this story from @MarketScope_LLC for information on initial clinical trial results, potential FDA approval timing & more: bit.ly/39IzUtD. #meniscustear #artificialmeniscus #NUsurface
"People who experience persistent knee pain even after surgery may soon be able to benefit from a revolutionary device — the world’s first artificial meniscus." - via @thetimesq8. #NUsurface #NUsurfaceImplant #meniscectomy #meniscustear
timeskuwait.com/news/new-dev…
It makes all of us at Active Implants happy that our NUsurface Meniscus Implant made this list as one of the "groundbreaking operations" performed in 2019. #menisustear #meniscussurgery #artificialmeniscus
israel21c.org/24-things-that…
We are excited to be named one of MD+DI's 20 private medtech companies to watch in 2020. #NUsurface #artificialmeniscus @MDDIonline
mddionline.com/20-private-co…
1
5
Our NUsurface Meniscus Implant – the world's first artificial #meniscus – was featured in @Healthline, highlighting our launch in the Middle East and progress in the U.S. healthline.com/health-news/a…
"Early Clinical Results of the NUsurface® Interpositional Knee Endoprosthesis versus Non-Surgical Controls: First 75 Patients of a Randomized Control Trial at 2 Years Follow-up" will be presented by Dr. Gabriel Agar at the Israeli Orthopaedic Association Annual Meeting Dec. 12.
6
"The NUsurface Meniscus Implant is the first 'artificial meniscus' to be marketed in Europe. If cleared by the US Food and Drug Administration (FDA), it would be the first artificial meniscus in the United States." - via @ISRAEL21C #meniscustear
israel21c.org/2-israeli-pati…
5
“This milestone is important because Active Implants developed and manufactures the implant here. This step demonstrates the successful collaboration between offices distributed in the U.S., Israel and Europe.” - Eran Ganz via @Ryortho1
Artificial Meniscus Now Commercially Available in Israel
@Active_Implants announced its #NUsurface Meniscus Implant—which the company claims is the world’s first “artificial meniscus”—has been commercially launched in Israel.
ryortho.com/breaking/artific…
#Meniscus
#Orthopedics
Read about our journey to market the NUsurface Meniscus Implant – the world's first artificial meniscus – in the Nov/Dec issue of MedTech Strategist's Market Pathways publication. Full story available for download on our website: bit.ly/33cZhQs.
“The NUsurface Implant has been extensively studied in clinical trials in Israel, Europe and the U.S." - Dr. Ron Arbel via @orthospinenews
orthospinenews.com/2019/11/1…
"After more than 10 years in clinical trials, it is an exciting time to finally be able to make the NUsurface Implant available to Israeli patients.” - Dr. Gabriel Agar via @TimesofIsrael
timesofisrael.com/two-patien…
Our NUsurface Meniscus Implant was invented and developed in our R&D center in Netanya, Israel, so it is very exciting to finally bring the device to people in Israel. #artificialmeniscus #meniscustear
businesswire.com/news/home/2…
Our President & CEO Ted Davis will be speaking at the Musculoskeletal New Ventures Conference at the FedEx Institute of Technology at The University of Memphis on Tuesday, October 29 at 2 p.m. #MNVC2019 @FedexInstitute @uofmemphis mnvc.org/
One-year data for the first 100 patients treated with the NUsurface Implant will presented by Dr. Wayne Gersoff at the German Congress of Orthopaedics and Traumatology Oct. 22 at 9:27 a.m. in Germany. View abstract: bit.ly/2BmSdFt. #NUsurface #meniscusimplant #DKOU2019
5









